Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. [PDF]
Arseneau RJ +10 more
europepmc +1 more source
Diagnostic Stratification of Pancreatic Ductal Adenocarcinoma via Metallomics and Blood-Based Biomarkers. [PDF]
Coradduzza D +12 more
europepmc +1 more source
FGF21 inhibits invasion and metastasis via IL-17A-Notch in pancreatic ductal adenocarcinoma. [PDF]
Li F +5 more
europepmc +1 more source
High CDCP1 Expression Reflects Immune and Stromal Remodeling and Oncogenic Signaling in Pancreatic Ductal Adenocarcinoma. [PDF]
Miyake K +9 more
europepmc +1 more source
Electroporation for the Treatment of Pancreatic Ductal Adenocarcinoma: A Systematic Review of Preclinical and Clinical Studies. [PDF]
Marcellier G +4 more
europepmc +1 more source
Insulin-like peptide 3 is not a biomarker for pancreatic ductal adenocarcinoma. [PDF]
Anand-Ivell R +4 more
europepmc +1 more source
Pancreatic ductal adenocarcinoma: the Everest of cancer biology. [PDF]
Than MT, Stanger BZ.
europepmc +1 more source
Analytical Validation of a Serum Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. [PDF]
Pescatore R +5 more
europepmc +1 more source
A Tissue-based Biomarker Risk Score for Predicting Survival in Pancreatic Ductal Adenocarcinoma. [PDF]
Kriz D +6 more
europepmc +1 more source

